Beneficial influence of nanocarbon on the aryliminopyridylnickel chloride catalyzed ethylene polymerization

A series of 1-aryliminoethylpyridine ligands (L1―L3) was synthesized by condensation of 2-acetylpyridine with 1-aminonaphthalene, 2-aminoanthracene or 1-aminopyrene, respectively. Reaction with nickel dichloride afforded the corresponding nickel (II) chloride complexes (Ni1–Ni3). All compounds were fully characterized and the molecular structures of Ni1 and Ni3 are reported. Upon activation with methylaluminoxane (MAO), all nickel complexes exhibit high activities for ethylene polymerization, producing waxes of low molecular weight and narrow polydispersity. The presence of multi-walled carbon nanotubes (MWCNTs) or few layer graphene (FLG) in the catalytic medium can lead to an increase of productivity associated to a modification of the polymer structure

Determination of the superconducting gap in near optimally doped Bi_2Sr_{2-x}La_xCuO_{6+\delta} (x ~ 0.4) from low-temperature specific heat

Low-temperature specific heat of the monolayer high-Tc superconductor Bi_2Sr_{2-x}La_xCuO_{6+\delta} has been measured close to the optimal doping point (x ~ 0.4) in different magnetic fields. The identification of both a T^2 term in zero field and a \sqrt{H} dependence of the specific heat in fields is shown to follow the theoretical prediction for d-wave pairing, which enables us to extract the slope of the superconducting gap in the vicinity of the nodes (v_{\Delta}, which is proportional to the superconducting gap \Delta_0 at the antinodes according to the standard d_{x^2-y^2} gap function). The v_{\Delta} or \Delta_0 (~ 12 meV) determined from this bulk measurement shows close agreement with that obtained from spectroscopy or tunneling measurements, which confirms the simple d-wave form of the superconducting gap.Comment: 5 pages, 4 figures, 1 tabl

Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.

Hypoxia-inducible factor 1α (HIF-1α) plays a critical role in the apoptotic process during cardiac ischaemia/reperfusion (I/R) injury. This study aimed to investigate whether post-treatment with dexmedetomidine (DEX) could protect against I/R-induced cardiac apoptosis in vivo and in vitro via regulating HIF-1α signalling pathway. Rat myocardial I/R was induced by occluding the left anterior descending artery for 30 minutes followed by 6-hours reperfusion, and cardiomyocyte hypoxia/reoxygenation (H/R) was induced by oxygen-glucose deprivation for 6 hours followed by 3-hours reoxygenation. Dexmedetomidine administration at the beginning of reperfusion or reoxygenation attenuated I/R-induced myocardial injury or H/R-induced cell death, alleviated mitochondrial dysfunction, reduced the number of apoptotic cardiomyocytes, inhibited the activation of HIF-1α and modulated the expressions of apoptosis-related proteins including BCL-2, BAX, BNIP3, cleaved caspase-3 and cleaved PARP. Conversely, the HIF-1α prolyl hydroxylase-2 inhibitor IOX2 partly blocked DEX-mediated cardioprotection both in vivo and in vitro. Mechanistically, DEX down-regulated HIF-1α expression at the post-transcriptional level and inhibited the transcriptional activation of the target gene BNIP3. Post-treatment with DEX protects against cardiac I/R injury in vivo and H/R injury in vitro. These effects are, at least in part, mediated via the inhibition of cell apoptosis by targeting HIF-1α signalling